glp-1 zepbound Weight-Loss Drug Now in Single-Dose Vials at Half the Price Zepbound leads to more weight

While the degree of change in BMI in published case reports, case series, and RCTs are inconclusive, GLP-1RAs may offer a new approach to HO treatment as the action of GLP-1 on appetite and energy regulation combines hypothalamic signaling and pathways that are independent of hypothalamic signaling

Brightness and uniformity

Neuroendocrinology 104 , 382397 (2017)

Despite the much-discussed results, this is not a randomized clinical trial, but a retrospective observational analysis

With projections indicating that over 50% of the population will be obese by 2030 1 , more FDA approvals of GLP-1s for obesity coming our way, and the social media craze, the pharmacy costs associated with GLP-1s are expected to skyrocket